Recurrence Pattern Analysis of Primary Glioblastoma

被引:88
作者
Rapp, Marion [1 ]
Baernreuther, Jessica [1 ]
Turowski, Bernd [2 ]
Steiger, Hans-Jakob [1 ]
Sabel, Michael [1 ]
Kamp, Marcel A. [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Med Fac, Dept Neurosurg, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Med Fac, Inst Diagnost & Intervent Radiol, Dusseldorf, Germany
关键词
Glioblastoma; Tumor recurrence pattern; RESECTION CLINICAL ARTICLE; NEWLY-DIAGNOSED PATIENTS; MALIGNANT GLIOMA; SURGICAL RESECTION; SUPRAMARGINAL RESECTION; ADJUVANT TEMOZOLOMIDE; CEREBRAL METASTASES; METHYLATION STATUS; GRADE GLIOMA; PHASE-III;
D O I
10.1016/j.wneu.2017.04.053
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Typical recurrence of glioblastoma occurs locally, usually within 2 cm from the original lesion. With improvement of surgical techniques, more aggressive surgical strategies have become feasible, resulting in a significantly increased rate of complete resection. We investigated whether these improvements are also reflected by tumor recurrence pattern. METHODS: Inclusion criteria were first diagnosis of glioblastoma with standard adjuvant radiochemotherapy and histologically proven tumor recurrence. Patients were divided according to recurrence pattern: local recurrence, distant recurrence, or both recurrence patterns. Data were correlated with extent of resection, molecular tumor configuration, clinical status, and survival data. RESULTS: This single-center retrospective study included 97 patients with glioblastoma treated between 2007 and 2014. Local, distant, and combined tumor recurrence patterns were observed in 77 (79.3%), 10 (10.3%), and 10 patients ( 10.3%). Median progression-free survival of all patients was 8 months; median overall survival was 20 months. Median progression-free survival was 7 months for patients with local recurrence, 13 months for patients with distant recurrence, and 9 months for patients with both recurrence patterns (P = 0.646). Median overall survival in the 3 groups was 21 months, 20 months, and 14 months (P = 0.098). No correlation between methylguaninee deoxyribonucleic acid methyltransferase methylation status and recurrence pattern was observed. CONCLUSIONS: Despite complete resection of contrast-enhancing tumor, most recurrences occurred locally. Patients with distant tumor recurrence demonstrated increased progression-free survival. Therefore, to gain local control, we may need to shift toward a more aggressive supramarginal resection, using extensive intraoperative monitoring to avoid permanent deficits.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 29 条
  • [1] Tailoring neurophysiological strategies with clinical context enhances resection and safety and expands indications in gliomas involving motor pathways
    Bello, Lorenzo
    Riva, Marco
    Fava, Enrica
    Ferpozzi, Valentina
    Castellano, Antonella
    Raneri, Fabio
    Pessina, Federico
    Bizzi, Alberto
    Falini, Andrea
    Cerri, Gabriella
    [J]. NEURO-ONCOLOGY, 2014, 16 (08) : 1110 - 1128
  • [2] Recurrence Pattern After Temozolomide Concomitant With and Adjuvant to Radiotherapy in Newly Diagnosed Patients With Glioblastoma: Correlation With MGMT Promoter Methylation Status
    Brandes, Alba A.
    Tosoni, Alicia
    Franceschi, Enrico
    Sotti, Guido
    Frezza, Giampiero
    Amista, Pietro
    Morandi, Luca
    Spagnolli, Federica
    Ermani, Mario
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1275 - 1279
  • [3] The influence of surgery on recurrence pattern of glioblastoma
    De Bonis, Pasquale
    Anile, Carmelo
    Pompucci, Angelo
    Fiorentino, Alba
    Balducci, Mario
    Chiesa, Silvia
    Lauriola, Libero
    Maira, Giulio
    Mangiola, Annunziato
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (01) : 37 - 43
  • [4] Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma
    Doerner, Lutz
    Mustafa, Ahmad
    Rohr, Axel
    Mehdorn, H. Maximilian
    Nabavi, Arya
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (03) : 429 - 434
  • [6] Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression
    Eisele, Gunter
    Wick, Antje
    Eisele, Anna-Carina
    Clement, Paul M.
    Tonn, Jorg
    Tabatabai, Ghazaleh
    Ochsenbein, Adrian
    Schlegel, Uwe
    Neyns, Bart
    Krex, Dietmar
    Simon, Matthias
    Nikkhah, Guido
    Picard, Martin
    Stupp, Roger
    Wick, Wolfgang
    Weller, Michael
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2014, 117 (01) : 141 - 145
  • [7] Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma
    Eyuepoglu, Ilker Y.
    Hore, Nirjhar
    Merkel, Andreas
    Buslei, Rolf
    Buchfelder, Michael
    Savaskan, Nicolai
    [J]. ONCOTARGET, 2016, 7 (18) : 25755 - 25768
  • [8] Maximizing safe resection of low- and high-grade glioma
    Hervey-Jumper, Shawn L.
    Berger, Mitchel S.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 130 (02) : 269 - 282
  • [9] ASSUMPTIONS IN THE RADIOTHERAPY OF GLIOBLASTOMA
    HOCHBERG, FH
    PRUITT, A
    [J]. NEUROLOGY, 1980, 30 (09) : 907 - 911
  • [10] Incidence of local in-brain progression after supramarginal resection of cerebral metastases
    Kamp, Marcel A.
    Rapp, Marion
    Slotty, Philipp J.
    Turowski, Bernd
    Sadat, Hosai
    Smuga, Maria
    Dibue-Adjei, Maxine
    Steiger, Hans-Jakob
    Szelenyi, Andrea
    Sabel, Michael
    [J]. ACTA NEUROCHIRURGICA, 2015, 157 (06) : 905 - 911